Karen Jacobson, PA-C | |
9135 Sw Barnes Rd Ste 985, Portland, OR 97225-6699 | |
(503) 297-3336 | |
(032) 973-3338 |
Full Name | Karen Jacobson |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 9135 Sw Barnes Rd Ste 985, Portland, Oregon |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588836654 | NPI | - | NPPES |
1588836654 | Medicaid | WI |
Mailing Address | Practice Location Address |
---|---|
Karen Jacobson, PA-C 9135 Sw Barnes Rd Ste 985, Portland, OR 97225-6699 Ph: (503) 297-3336 | Karen Jacobson, PA-C 9135 Sw Barnes Rd Ste 985, Portland, OR 97225-6699 Ph: (503) 297-3336 |
News Archive
Cancer is the leading cause of death in Canada, making end-of-life care a growing concern as the population ages. This year's annual Canadian Cancer Statistics report, released by the Canadian Cancer Society, highlights the often heartbreaking challenges faced by dying cancer patients and their friends and family members who often take on the role of caregivers.
Cardiovascular Systems, Inc. (CSI), has received Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to evaluate the safety and effectiveness of its Diamondback 360® System in the treatment of calcified coronary lesions. With this conditional approval, CSI is authorized to begin its pivotal trial, ORBIT II, in early 2010 and initially enroll up to 100 patients at as many as 50 U.S. sites.
An autism intervention program that emphasizes social interactions and is designed for children as young as 12 months has been found to improve cognitive skills and brain responses to faces, considered a building block for social skills. The researchers say that the study, which was completed at the University of Washington, is the first to demonstrate that an intensive behavioral intervention can change brain function in toddlers with autism spectrum disorders.
Xcelience is proud to announce the grand opening of its new 71,000 square foot headquarters located at 4910 Savarese Circle in Tampa. The building houses preformulation and formulation development labs and suites, as well as analytical and stability services. The official ribbon cutting ceremony was attended by Florida Governor Rick Scott, Tampa Mayor Bob Buckhorn and other elected and non-elected officials.
Professor Paul Bissell's recent articles have cast doubt on patient and public involvement as a means of bringing real-world experience to treatments.
› Verified 5 days ago